Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Nucleic acid molecule for reduction of PAPD5 and PAPD7 mRNA for treating hepatitis B infection

Nucleic acid molecule for reduction of PAPD5 and PAPD7 mRNA for treating hepatitis B infection

US Patent 11484546 · Granted Nov 1, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Oligonucleotides for modulating RTEL1 expression2025
Oligonucleotides for modulating RTEL1 expression2025
Nucleic acid molecule for reduction of PAPD5 and PAPD7 mRNA for treating hepatit2025
Nucleic acid molecule for reduction of PAPD5 and PAPD7 mRNA for treating hepatit2025
Nucleic acid molecule for reduction of PAPD5 and PAPD7 mRNA for treating hepatit2025
Nucleic acid molecule for reduction of PAPD5 and PAPD7 mRNA for treating hepatit2025
Oligomers and oligomer conjugates2025
Oligonucleotides for inducing paternal UBE3A expression2025
Oligonucleotides for modulating SCN9A expression2024
Enhanced oligonucleotides for inhibiting RTEL1 expression2024
Enhanced oligonucleotides for inhibiting RTEL1 expression2024
Enhanced oligonucleotides for inhibiting RTEL1 expression2024